• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Plasma Pen Treatments with Jason Emer, MD


Jason Emer, MD, in this video interview, discusses plasma pen cosmetic treatments, the influx of patient interest, dangers of non-FDA cleared pens, and how to work with SOC patients.

Jason Emer, MD, a board-certified dermatologic surgeon, Los Angeles, California, demonstrated the PlasmaMD pen for facial rejuvenation treatment at the Aesthetics Biomedical’s Perspectives: The Evolution of Aesthetics symposium.

The PlasmaMD is a compact handheld device for nonsurgical skin rejuvenation and is FDA Class II cleared for soft tissue coagulation and lesion. It has been promoted over social media, which has caused patient interest in the treatments to increase. 

Emer talks about the following in this interview:

  • His demonstration and how plasma treatments have changed the aesthetics field. 
  • How the plasma pen has its limits as a procedure and how he explains that to patients.
  • How dangerous non-FDA cleared plasma pens are along with their adverse events.
  • The conversation needed with skin of color (SOC) patients beforehand about hyperpigmentation risks and other concerns.

To listen, click the video below.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.